The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer.
Lishi LinMarcel SoesanDorieke E M van BalenJos H BeijnenAlwin D R HuitemaPublished in: Breast cancer research and treatment (2022)
BMI did not significantly influence the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy. Therefore, the results of this study align with current guideline recommendations of using full-weight-based paclitaxel chemotherapy in obese patients.
Keyphrases
- body mass index
- weight gain
- obese patients
- chemotherapy induced
- early stage
- bariatric surgery
- weight loss
- physical activity
- locally advanced
- randomized controlled trial
- systematic review
- open label
- roux en y gastric bypass
- gastric bypass
- double blind
- clinical trial
- body weight
- clinical practice
- rectal cancer
- lymph node
- young adults